Andrographolide inhibits NF-kB activation and attenuates neointimal hyperplasia in arterial restenosis

Cell Research

Volumn 17, Issue 11, 2007, Pages 933-941

  Wang, Yu Jiu ^a   Wang, Jin Tao ^b   Fan, Quan Xin ^a   Geng, Jian Guo ^b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Andrographolide; Arterial restenosis; E selectin; Neointimal hyperplasia; NF ?B transcription factors; TF; VCAM 1

Indexed keywords

ANDROGRAPHOLIDE; CD68 ANTIGEN, HUMAN; CD68 PROTEIN, MOUSE; CYSTEINE; DIFFERENTIATION ANTIGEN; DITERPENE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOCYTE ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; THROMBOPLASTIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL; ARTICLE; BIOSYNTHESIS; CORONARY BLOOD VESSEL; DISEASE MODEL; DRUG EFFECT; GENE DELETION; GENETICS; HUMAN; HYPERPLASIA; INFLAMMATION; INTIMA; MACROPHAGE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; RESTENOSIS; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CORONARY RESTENOSIS; CORONARY VESSELS; CYSTEINE; DISEASE MODELS, ANIMAL; DITERPENES; E-SELECTIN; GENE DELETION; HUMANS; HYPERPLASIA; INFLAMMATION; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; THROMBOPLASTIN; TUNICA INTIMA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

MURINAE; MUS;

EID: 36248995912     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2007.89     Document Type: Article

References (30)

1. Schmitz ML, Mattioli I, Buss H, Kracht M. NF-κB: a multifaceted transcription factor regulated at several levels. Chembiochem 2004; 5:1348-1358.
2. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2:725-734.
3. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 2001; 7:1291-1297.
4. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107:135-142.
5. Cercek B, Yamashita M, Dimayuga P, et al. Nuclear factor-kappaB activity and arterial response to balloon injury. Atheroscle rosis 1997; 131:59-66.
6. Lindner V. The NF-kappaB and IkappaB system in injured arteries. Pathobiology 1998; 66:311-320.
7. Landry DB, Couper LL, Bryant SR, Lindner V. Activation of the NF-kappa B and Ikappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 1997; 151:1085-1095.
8. Squadrito F, Deodato B, Bova A, et al. Crucial role of nuclear factor-kappaB in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow. Atherosclerosis 2003; 166:233-242.
9. Xia YF, Ye BQ, Li YD, et al. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol 2004; 173:4207- 4217.
10. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343:757-760.
11. Mercurio AM, Schwarting GA, Robbins PW Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J Exp Med 1984; 160:1114-1125.
12. Marelli-Berg FM, Peek E, Lidington EA, et al. Isolation of endothelial cells from murine tissue. J Immunol Methods 2000; 244:205-215.
13. Ozcan M, Morton CT, Solovey A, et al. Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantation. Thromb Haemost 2001; 85:250-255.
14. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997; 17:2238-2244.
15. Sirsjo A, Lofving A, Hansson GK, Wagsater D, Tokuno S, Valen G. Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injury. J Cardiovasc Pharmacol 2003; 41:897-902.
16. Wang B, Xiao Y, Ding BB, et al. Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003; 4:19-29.
17. Geng JG, Raub TJ, Baker CA, et al. Expression of a P-selectin ligand in zona pellucida of porcine oocytes and P-selectin on acrosomal membrane of porcine sperm cells. Potential implications for their involvement in sperm-egg interactions. J Cell Biol 1997; 137:743-754.
18. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular adhesion molecule 1 promoter. J Exp Med 1992; 176:1583-1593.
19. Whitley MZ, Thanos D, Read MA, Maniatis T, Collins T. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol 1994; 14:6464-6475.
20. Shu HB, Agranoff AB, Nabel EG, et al. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-κB subunits in endothelial and epithelial cells. Mol Cell Biol 1993; 13:6283-6289.
21. Tilley R, Mackman N. Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost 2006; 32:5-10.
22. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106:1604-1611.
23. Morrissey JH. Tissue factor: in at the start...and the finish? J Thromb Haemost 2003; 1:878-880.
24. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005; 3:1590-1596.
25. Bu DX, Erl W, de Martin R, Hansson GK, Yan ZQ. IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimai hyperplasia. FASEB J 2005; 19:1293-1295.
26. Inagaki H, Suzuki J, Ogawa M, Taniyama Y, Morishita R, Isobe M. Ultrasound-microbubble-mediated NF-kappaB decoy transfection attenuates neointimal formation after arterial injury in mice. J Vasc Res 2006; 43:12-18.
27. Kalinowski M, Viehofer K, Hamann C, et al. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits. Cardiovasc Interven Radiol 2005; 28:331-337.
28. Miyake T, Aoki M, Shiraya S, et al. Inhibitory effects of NF-kappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol 2006; 41:431-440.
29. Ouchida R, Kusuhara M, Shimizu N, et al. Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Genes Cells 2003; 8:95-107.
30. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78:747-754.